Long-term use of tirzepatide shows sustained and significant weight loss in adults with overweight or obesity.

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that the internationally recognized body mass index (BMI) cut-off points greatly ...

New research presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that the ...

Parents of children with spinal muscular atrophy (SMA), a rare disease, welcomed the announcement by the Indian pharma ...

At 42, Moumita Ghosh proved that weight loss isn’t just for the young. Without crash diets or fancy programs, this school ...

Many individuals, like Bangalore's Sristi, find that simply increasing protein intake doesn't guarantee weight loss. While protein is essential, exper ...

In 2022, the SURMOUNT-1 trial initially found that adults randomized to tirzepatide for 72 weeks lost on ... (a BMI of at ...

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that around two thirds of participants of the SURMOUNT-1 trial had only regained 5% ...

New research to be presented at the European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that around ...